Tudor Investment Corp ET AL acquired a new position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report) during the 4th quarter, HoldingsChannel reports. The fund acquired 75,134 shares of the medical instruments supplier’s stock, valued at approximately $1,426,000.
Several other hedge funds have also added to or reduced their stakes in XRAY. Pacer Advisors Inc. increased its stake in shares of DENTSPLY SIRONA by 15,105.1% during the 4th quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier’s stock worth $85,478,000 after purchasing an additional 4,473,972 shares during the last quarter. Nuance Investments LLC raised its stake in shares of DENTSPLY SIRONA by 25.0% in the fourth quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier’s stock valued at $257,103,000 after buying an additional 2,708,097 shares during the period. Norges Bank bought a new stake in shares of DENTSPLY SIRONA in the fourth quarter valued at $45,730,000. Price T Rowe Associates Inc. MD grew its stake in shares of DENTSPLY SIRONA by 18.7% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier’s stock worth $238,186,000 after acquiring an additional 1,975,404 shares during the period. Finally, Cooke & Bieler LP increased its holdings in DENTSPLY SIRONA by 24.3% in the 4th quarter. Cooke & Bieler LP now owns 9,172,876 shares of the medical instruments supplier’s stock worth $174,101,000 after acquiring an additional 1,794,391 shares during the last quarter. Institutional investors own 95.70% of the company’s stock.
Analysts Set New Price Targets
XRAY has been the topic of several recent research reports. StockNews.com downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Friday, February 28th. Wells Fargo & Company cut their price objective on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an “equal weight” rating for the company in a report on Friday, February 28th. Mizuho lowered their target price on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating on the stock in a report on Thursday, March 13th. Needham & Company LLC reaffirmed a “hold” rating on shares of DENTSPLY SIRONA in a report on Thursday, March 13th. Finally, Barrington Research decreased their price objective on DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating on the stock in a research note on Friday, February 28th. Thirteen investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $21.25.
Insider Buying and Selling
In other news, Director Gregory T. Lucier purchased 15,142 shares of the company’s stock in a transaction on Monday, March 3rd. The stock was purchased at an average price of $16.51 per share, with a total value of $249,994.42. Following the completion of the purchase, the director now directly owns 81,971 shares in the company, valued at approximately $1,353,341.21. This trade represents a 22.66 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 0.52% of the stock is owned by company insiders.
DENTSPLY SIRONA Stock Down 1.7 %
XRAY stock opened at $13.84 on Tuesday. DENTSPLY SIRONA Inc. has a 1-year low of $12.16 and a 1-year high of $29.13. The stock has a market cap of $2.76 billion, a price-to-earnings ratio of -6.69, a price-to-earnings-growth ratio of 1.80 and a beta of 0.92. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The company’s 50 day moving average is $14.49 and its 200 day moving average is $17.80.
DENTSPLY SIRONA Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 28th were issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.62%. The ex-dividend date of this dividend was Friday, March 28th. DENTSPLY SIRONA’s dividend payout ratio is currently -14.07%.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Featured Articles
- Five stocks we like better than DENTSPLY SIRONA
- Health Care Stocks Explained: Why You Might Want to Invest
- Monster Beverage Stock: Short Report Risks vs Upside Potential
- How to Calculate Inflation Rate
- Onsemi Stock Confirms Bottom, But What’s the Upside?
- How to Invest in Small Cap StocksÂ
- 3 Tech Leaders Announce Buybacks Totaling $85 Billion
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Free Report).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.